242 related articles for article (PubMed ID: 16376101)
21. CD4+CD25+-regulatory T cells from mouse to man.
Wing K; Suri-Payer E; Rudin A
Scand J Immunol; 2005 Jul; 62(1):1-15. PubMed ID: 16091121
[TBL] [Abstract][Full Text] [Related]
22. Regulatory T cells: magic bullets for immunotherapy?
Frey O; Bräuer R
Arch Immunol Ther Exp (Warsz); 2006; 54(1):33-43. PubMed ID: 16642255
[TBL] [Abstract][Full Text] [Related]
23. The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression.
Ghiringhelli F; Ménard C; Martin F; Zitvogel L
Immunol Rev; 2006 Dec; 214():229-38. PubMed ID: 17100888
[TBL] [Abstract][Full Text] [Related]
24. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
25. Regulatory T cells under scrutiny.
Bach JF
Nat Rev Immunol; 2003 Mar; 3(3):189-98. PubMed ID: 12658267
[TBL] [Abstract][Full Text] [Related]
26. Increased CD4CD25+FOXP3+ regulatory T Cells in cancer patients from conversion of CD4+CD25- T cells through tumor-derived factors.
Mao C; Wang S; Jiang Q; Tong J; Ma J; Yang M; Xu X; Qiu G; Shao Q; Li L; Xu H
Onkologie; 2008 May; 31(5):243-8. PubMed ID: 18497513
[TBL] [Abstract][Full Text] [Related]
27. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
28. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells.
Keino H; Takeuchi M; Kezuka T; Hattori T; Usui M; Taguchi O; Streilein JW; Stein-Streilein J
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1047-55. PubMed ID: 16505040
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
[TBL] [Abstract][Full Text] [Related]
30. Does chemotherapy augment anti-tumor immunotherapy by preferential impairment of regulatory T cells?
Zhang L; Dermawan KT; Jin ML; Xiong SD; Chu YW
Med Hypotheses; 2008 Nov; 71(5):802-4. PubMed ID: 18691831
[TBL] [Abstract][Full Text] [Related]
31. Functional control of regulatory T cells and cancer immunotherapy.
Wang RF
Semin Cancer Biol; 2006 Apr; 16(2):106-14. PubMed ID: 16423537
[TBL] [Abstract][Full Text] [Related]
32. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
Kiniwa Y; Miyahara Y; Wang HY; Peng W; Peng G; Wheeler TM; Thompson TC; Old LJ; Wang RF
Clin Cancer Res; 2007 Dec; 13(23):6947-58. PubMed ID: 18056169
[TBL] [Abstract][Full Text] [Related]
33. Multiple roles for CD4+ T cells in anti-tumor immune responses.
Kennedy R; Celis E
Immunol Rev; 2008 Apr; 222():129-44. PubMed ID: 18363998
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis.
George J
Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):531-40. PubMed ID: 18607396
[TBL] [Abstract][Full Text] [Related]
35. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
[TBL] [Abstract][Full Text] [Related]
36. Differential influence of the tumour-specific non-human sialic acid containing GM3 ganglioside on CD4+CD25- effector and naturally occurring CD4+CD25+ regulatory T cells function.
de León J; Fernández A; Clavell M; Labrada M; Bebelagua Y; Mesa C; Fernández LE
Int Immunol; 2008 Apr; 20(4):591-600. PubMed ID: 18310617
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
38. Regulatory T cells: how do they find their space in the immunological arena?
D'Ambrosio D
Semin Cancer Biol; 2006 Apr; 16(2):91-7. PubMed ID: 16384712
[TBL] [Abstract][Full Text] [Related]
39. T-helper/T-regulator lymphocyte ratio as a new immunobiological index to quantify the anticancer immune status in cancer patients.
Brivio F; Fumagalli L; Parolini D; Messina G; Rovelli F; Rescaldani R; Vigore L; Vezzo R; Vaghi M; Di Bella S; Lissoni P
In Vivo; 2008; 22(5):647-50. PubMed ID: 18853761
[TBL] [Abstract][Full Text] [Related]
40. Emerging strategies in regulatory T-cell immunotherapies.
Gajewski TF; Chesney J; Curriel TJ
Clin Adv Hematol Oncol; 2009 Jan; 7(1):1-10; quiz 11-2. PubMed ID: 19288606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
